Profile data is unavailable for this security.
About the company
Shiseido Co Ltd is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, personal care products, barber and beauty products. The Company operates through six business segments. The Japan segment is engaged in the sale of cosmetics, fragrance, toiletries, personal care products, beauty food and over-the-counter drugs in Japan. China segment and Asia Pacific segment is engaged in the manufacture and sale of cosmetics, toiletries and personal care products respectively in China and Asia-Oceania other region. Americas segment and Europe segment is engaged in the manufacture and sale of cosmetics and toiletries respectively in the Americas, as well as Europe, the Middle East and Africa. Travel Retail segment is engaged in the sale of cosmetics and toiletries in duty free shops around the world. The Company also conducts manufacturing businesses and food and beverage businesses.
- Revenue in JPY (TTM)969.37bn
- Net income in JPY-3.84bn
- Incorporated1927
- Employees27.91k
- LocationShiseido Co Ltd1-6-2, Higashi-ShimbashiMINATO-KU 105-8310JapanJPN
- Phone+81 335725111
- Fax+81 335748380
- Websitehttps://corp.shiseido.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pigeon Corp | 105.65bn | 8.80bn | 206.51bn | 3.07k | 23.08 | 2.66 | 14.94 | 1.95 | 73.55 | 73.55 | 883.43 | 639.31 | 1.04 | 3.63 | 5.66 | 34,458,250.00 | 8.81 | 9.07 | 10.88 | 11.15 | 49.81 | 48.49 | 8.51 | 9.20 | 3.15 | -- | 0.00 | 102.24 | 10.28 | 0.8172 | 12.77 | -6.22 | -10.95 | 1.66 |
| PALTAC Corp | 1.19tn | 22.86bn | 258.49bn | 2.28k | 11.20 | 0.8797 | 8.80 | 0.2176 | 366.27 | 366.27 | 19,042.22 | 4,664.19 | 2.37 | 20.73 | 5.65 | 520,410,400.00 | 4.56 | 4.38 | 7.80 | 7.71 | 7.49 | 7.62 | 1.92 | 1.84 | 1.49 | -- | 0.0026 | 26.62 | 3.14 | 2.57 | 10.79 | -2.09 | -37.94 | 8.45 |
| Pola Orbis Holdings Inc | 170.79bn | 7.47bn | 291.23bn | 4.02k | 37.68 | 1.76 | 18.38 | 1.71 | 33.73 | 33.73 | 771.52 | 722.89 | 0.8738 | 1.86 | 10.46 | 42,473,520.00 | 3.83 | 4.55 | 4.41 | 5.20 | 81.41 | 82.33 | 4.38 | 5.43 | 3.50 | 13.49 | 0.0003 | 121.71 | -1.70 | -4.98 | -3.92 | -13.96 | 5.46 | -8.25 |
| Kose Corp | 324.17bn | 5.86bn | 348.35bn | 8.13k | 55.99 | 1.21 | 18.50 | 1.07 | 102.68 | 102.68 | 5,680.88 | 4,738.09 | 0.8634 | 1.35 | 6.62 | 39,873,680.00 | 2.02 | -- | 2.61 | -- | 68.81 | -- | 2.34 | -- | 2.24 | 95.39 | 0.0348 | -- | 7.44 | -- | -35.61 | -- | -- | -- |
| Lion Corp | 414.21bn | 21.68bn | 406.24bn | 7.65k | 18.56 | 1.39 | 8.90 | 0.9808 | 78.24 | 78.24 | 1,496.21 | 1,045.50 | 0.8943 | 3.76 | 6.15 | 54,117,320.00 | 5.32 | 5.37 | 7.65 | 8.35 | 45.53 | 46.85 | 5.95 | 6.29 | 1.45 | -- | 0.0929 | 32.10 | 2.53 | 3.51 | 44.95 | 0.6131 | -1.88 | 5.15 |
| Kobayashi Pharmaceutical Co Ltd | 161.72bn | 10.72bn | 406.95bn | 3.62k | 36.17 | 1.87 | 21.26 | 2.52 | 144.14 | 144.14 | 2,175.64 | 2,785.30 | 0.6305 | 2.88 | 4.61 | 44,736,380.00 | 4.18 | 7.07 | 5.08 | 8.89 | 51.53 | 55.52 | 6.63 | 11.02 | 2.64 | -- | 0.0038 | 38.66 | -4.53 | 0.9006 | -50.50 | -12.06 | 40.85 | 6.92 |
| Shiseido Co Ltd | 969.37bn | -3.84bn | 1.01tn | 27.91k | -- | 1.64 | 13.93 | 1.04 | -9.62 | -9.62 | 2,426.10 | 1,534.50 | 0.7381 | 1.46 | 6.22 | 34,734,630.00 | -0.1871 | 1.46 | -0.2795 | 2.17 | 76.61 | 73.11 | -0.2535 | 1.87 | 0.7887 | 33.75 | 0.3665 | 144.14 | 1.80 | -2.63 | -149.72 | -- | -14.63 | -7.79 |
| Unicharm Corp | 980.22bn | 88.92bn | 1.92tn | 16.46k | 20.36 | 2.38 | 12.89 | 1.95 | 50.52 | 50.52 | 556.84 | 431.92 | 0.8353 | 5.28 | 6.61 | 59,537,170.00 | 8.62 | 8.17 | 12.46 | 12.26 | 39.41 | 38.63 | 10.32 | 9.63 | 1.86 | -- | 0.0285 | 30.89 | 5.01 | 6.73 | -4.89 | 12.16 | -2.23 | 9.46 |
| Kao Corp | 1.65tn | 114.15bn | 3.06tn | 32.57k | 26.72 | 2.96 | 15.00 | 1.85 | 245.73 | 245.73 | 3,557.38 | 2,214.88 | 0.9323 | 3.55 | 7.41 | 50,743,350.00 | 6.55 | 5.62 | 8.98 | 7.76 | 39.30 | 38.75 | 7.02 | 6.46 | 1.22 | -- | 0.1887 | 72.82 | 6.26 | 1.63 | 145.30 | -6.11 | -6.37 | 3.18 |
| Holder | Shares | % Held |
|---|---|---|
| Independent Franchise Partners LLPas of 20 Jun 2025 | 32.67m | 8.17% |
| Norges Bank Investment Managementas of 05 Feb 2025 | 25.58m | 6.40% |
| Nomura Asset Management Co., Ltd.as of 20 May 2025 | 24.82m | 6.20% |
| Baillie Gifford & Co.as of 13 Dec 2024 | 16.26m | 4.07% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 13.56m | 3.39% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Apr 2025 | 12.62m | 3.15% |
| BlackRock Fund Advisorsas of 28 Jun 2024 | 12.61m | 3.15% |
| Nikko Asset Management Co., Ltd.as of 30 Apr 2025 | 11.98m | 3.00% |
| Asset Management One Co., Ltd.as of 30 Jun 2025 | 11.15m | 2.79% |
| Daiwa Asset Management Co. Ltd.as of 30 May 2025 | 10.70m | 2.68% |
